Rubicon Research rises on incorporating wholly owned subsidiary in Saudi Arabia

14 Jan 2026 Evaluate

Rubicon Research is currently trading at Rs. 679.30, up by 2.35 points or 0.35% from its previous closing of Rs. 676.95 on the BSE.

The scrip opened at Rs. 636.50 and has touched a high and low of Rs. 682.50 and Rs. 636.50 respectively. So far 3640 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 887.95 on 18-Nov-2025 and a 52 week low of Rs. 571.00 on 24-Oct-2025.

Last one week high and low of the scrip stood at Rs. 696.35 and Rs. 627.90 respectively. The current market cap of the company is Rs. 11190.66 crore.

The promoters holding in the company stood at 59.99%, while Institutions and Non-Institutions held 19.12% and 20.89% respectively.

Rubicon Research has incorporated a wholly owned subsidiary -- AdvaGen S A Company in the Kingdom of Saudi Arabia on January 13, 2026. The AdvaGen S A Company will deal in pharmaceutical products. The cost of subscription of AdvaGen S A Company’s shares was 1 lakh Saudi Riyal. 

Rubicon Research is a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of speciality products and drug-device combination products targeting regulated markets and in particular the United States.

Rubicon Research Share Price

682.55 0.00 (0.00%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Wework India Managem 600.40
Rubicon Research 682.55
Aegis Vopak Terminal 225.70
Mallcom 1084.85
Inducto Steel 50.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×